Ophthalmology Pakistan. A double blind peer reviewed journal. ISO Abbreviation = Ophthalmol. Pak.


Online Submissions

Already have a Username/Password for Ophthalmology Pakistan?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.


Author Guidelines


The article should be written under the following headlines:

      Title page
      Abstract: Maximum of 360 words
      Figure legends, tables and figures, if not embedded in the text (Pages should be numbered).

Title page
The title page, which must be part of the main file, should include the title (running title), authors’ names and institutional affiliation. The title must be less than 150 characters, including punctuation marks and spaces. There should be no abbreviation, trade names or chemical formulae.

The structured abstract of fewer than 300 words should be arranged under the following headings: Purpose, Material & Methods, Results, and Conclusions. Define abbreviations at the first mention and do not include references.

The main text should consist of 4000 or fewer words, excluding title page, legends, and references. The text size should be 12 points, Arial font typed at double line space.

In a brief introduction provide the research background, rationale, and objectives without extensively reviewing the literature.
In the Methods section, describe the study design, subjects used, sampling strategy and procedures followed. Previously published or standard procedures may be identified by reference only. Use standard chemical or non-proprietary pharmaceutical nomenclature. Brand name, company, city, and state or country could follow within brackets.
If human subjects were involved in the investigations, the Methods section must confirm that: (1) the research was conducted under the guidelines provided by Declaration of Helsinki (1964 and its further amendments); (2) informed consent was obtained from the subjects after explanation of the nature and possible applicable, the research was approved by the institutional research/ ethical committee or institutional review board (IRB).
If experimental animals were used in the investigation, the Methods section must confirm adherence to the Guide for the Care and Use of Laboratory Animals (NRC 1996) and, where applicable, approved by the appropriate institutional review board (IRB).
Present the Results along with the Discussion or separately. Cite all tables and figures in numerical order. Do not repeat the data provided in figures or graphs in results. Limit the discussion to statistically significant and relevant data.
Please proof-read your article for language. Grammatical and spelling errors carefully prior to submission.

Acknowledgments should be written in the third person and be limited to colleagues and research assistants. COAVS journal policy does not allow dedications or acknowledgments to individuals or groups supporting the research financially or materially.

List references numerically by order of citation in the text, according to the Vancouver style of referencing. All references must be cited in the text or tables, shown as superscript numbers. Authors are responsible for the accuracy of references.
Unpublished data (including material in preparation or submitted) or personal communications should be listed parenthetically in the text only with year received only with year received or recorded.
References to books should include (1) author(s), (2) chapter title (if any), (3) editors (if any), (4) Title of book with edition number if other than the first edition, (5) city of publication, (6) publisher, (7) year, and (8) inclusive page numbers.
For further assistance see the official website of International Committee of Medical Journal Editors for the document “Uniform Requirements for Manuscripts Submitted to Biomedical Journals or follow the links:

Tables, legends, figures.

  1. Tables must be included in the main manuscript file each table should have a brief, self-contained title, understandable without reference to the text column. Footnotes in the table should use symbols in the following sequence: *,†, ‡, §, ||, and #. A date that can be given in the text in two or three sentences should not be presented in table format.
  2. Legends should describe the content of data contained in the figure.
  3. Figures should be cited in the text, in numerical order using Arabic numerals. Figures may be placed within the main manuscript file or uploaded separately with one figure on a separate page along with its label. If a figure contains multiple parts, it should be assembled on one page; Figures 1A and 1B should not appear on separate pages.
  4. Please Label each figure appropriately just beneath the inserted image. For example, labels should read “Fig. 1” or “Figure 1.”  


The main manuscript document must be submitted in Microsoft Word (.doc or .docx) format; Mac users should manually type in the .doc extension at the end of the file name when they save their document.

Use initial caps and a descriptive clause for titles and subheadings, avoiding complete sentences or questions. Keep abbreviations and acronyms to a minimum and define them at first mention.
Use System International (SI) measurements throughout the paper. http://physics.nist.gov/cuu/units/units



Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

  1. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.
  2. I have not submitted this article before to any other journal for publication.
  3. I declare that none of the authors has any significant competing financial, professional or personal interests that might have influenced the performance or presentation of the work described in this manuscript. If anyone has so, this is mentioned in Competing Interest (CI Policy) under that author's profile.
  4. I agree to indemnify Ophthalmology Pakistan and the Publisher and hold it harmless from all damages and all reasonable expenditures incurred by the Journal/Publisher as the result of any charge or claim of copyright infringement or violation of proprietary rights asserted against the Journal/Publisher by third parties as a result of the Journal/Publisher use and publication of the manuscript
  5. All authors have contributed to the work and are familiar with the primary data; each has read the final manuscript, and approved its contents.
  6. All authors have agreed to have their name added to the paper.
  7. All persons who have made substantial contributions to the work reported in this manuscript are included as authors, or are acknowledged (this includes anyone who may have been paid to draft or revise the paper).
  8. The manuscript is free of falsification, fabrication, plagiarism and self-plagiarism. All applicable principles of scientific integrity, including ethical treatment of human subjects and humane treatment of animals, have been followed. In signing this form you testify that an appropriate institutional or public board approved the protocols for human or animal subject use
  9. All funding sources that supported the work are acknowledged. Any potential conflicts of interest on the part of any authors have been supplied as part of the submission process. By signing this form I agree I will examine typeset proofs as supplied by the publisher prior to publication to ensure all relevant financial disclosures and other potential conflicts of interest have been accurately included within the manuscript
  10. If any identifying information about patients is included in the article, an additional informed consent was obtained from all patients for which identifying information is included in this article.
  11. I have read the instructions to authors thoroughly. https://www.ophthalmologypakistan.com/op/index.php/OP/about/submissions#authorGuidelines


Copyright Notice


The copyright in this website and the material on this website (including without limitation the text, computer code, artwork, photographs, images, music, audio material, video material and audio-visual material on this website) is owned by OPHTHALMOLOGY PAKISTAN.



OPHTHALMOLOGY PAKISTAN grants to you a worldwide non-exclusive royalty-free revocable license to:

a) view this website and the material on this website on a computer or mobile device via a web browser;

b) copy and store this website and the material on this website in your web browser cache memory; and

c) print pages from this website for your use.

d) OPHTHALMOLOGY PAKISTAN permits all published articles to be copied, redistributed, remixed, transmitted and the work be adapted provided the original work and source is appropriately cited.

OPHTHALMOLOGY PAKISTAN does not grant any other rights in relation to this website or the material on this website. In other words, all other rights are reserved.

For the avoidance of doubt, you must not adapt, edit, change, transform, publish, republish, distribute, redistribute, broadcast, rebroadcast or show or play in public this website or the material on this website (in any form or media) without appropriately and conspicuously citing the original work and source or OPHTHALMOLOGY PAKISTAN prior written permission.



You may request permission to use the copyright materials on this website by writing to chiefeditor@ophthalmologypakistan.com.



OPHTHALMOLOGY PAKISTAN takes the protection of its copyright very seriously.

If OPHTHALMOLOGY PAKISTAN discovers that you have used its copyright materials in contravention of the license above, OPHTHALMOLOGY PAKISTAN may bring legal proceedings against you seeking monetary damages and an injunction to stop you using those materials. You could also be ordered to pay legal costs.

If you become aware of any use of OPHTHALMOLOGY PAKISTAN' copyright materials that contravenes or may contravene the license above, please report this by email to chiefeditor@ophthalmologypakistan.com.

Infringing material

If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to chiefeditor@ophthalmologypakistan.com.


Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.